Published in Cancer Weekly, April 19th, 2005
Product sales in the second quarter were $768 thousand, up from $509 thousand in the same quarter last year, an increase of 51%. The net loss for the quarter was $1.4 million or $0.03 per share compared with $1.0 million or $0.02 per share in the same period last year.
For the 6 months ended January 31, 2005, product sales were $1.7 million, up from $1.1 million for the same period last year, an increase of 53%. The net loss of the 6 month period was $2.6 million or $0.06 per share compared to $1.9 million or $0.05 per share for the same...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.